Overview

Crofelemer for Functional Diarrhea

Status:
Recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

The primary objectives of this study are to evaluate the clinical response of patients with diarrhea to crofelemer relative to placebo and evaluate the overall safety and tolerability of crofelemer in the treatment of diarrhea.

Phase:

Phase 4

Details

Lead Sponsor:

Beth Israel Deaconess Medical Center